Resource Hub


Topic : News and Press Type : Press Release

The Association of British HealthTech Industries (ABHI) and the CPI have entered into a partnership to stimulate innovation development and fuel growth of the UK’s SME HealthTech sector.

The collaboration will support the UK’s SME business community cultivate research, development and innovation capability and bolster manufacturing in the UK. A particular focus will be to catalyse the commercialisation of diagnostic innovations to address unmet population health needs.

CPI, which is part of the UK’s High Value Manufacturing Catapult, is a leading technology innovation centre, working with a range of clients to translate research into the marketplace. With significant breadth of expertise and innovation facilities across medicines manufacturing, flexible hybrid electronics and photonics, advanced materials, biotechnology and digital, CPI are utilising their capabilities to support the HealthTech market, with a particular focus on point-of-need diagnostics, wearables and the burgeoning digital healthcare sector.

ABHI, the UK’s leading industry association for health technology, supports its 300 members to provide products and technologies to patients in the UK and abroad. Small businesses make up a significant group and the partnership with CPI is part of a refreshed effort to provide SMEs with a one-stop service to research, prototype and manufacture their innovations. ABHI was recently tasked by Parliamentary Under-Secretary of State for Innovation, Lord Bethell, to develop a strategy to invest in “resilient, scalable and holistic” diagnostics capability for our country, which this strategic relationship will complement.

Nishan Sunthares, Chief Operating Officer, ABHI said: “I am delighted to announce this partnership with CPI to boost SME growth. By bringing ABHI’s expertise in areas such as regulation, innovation adoption and health policy, closer to CPI’s significant technology development capabilities, I am excited about the support we can deliver to the many small UK HealthTech companies, to scale up their operations, and promote excellence across the industry.”

Dr Arun Harish, Strategy Director at CPI said: “We are delighted to be forming a partnership with an organisation that brings significant value to HealthTech companies. This partnership will enable us to support more companies to develop their innovative products at reduced risk, by providing access to world-class facilities and finance and leading experts in commercialising medical technologies”.

About ABHI
ABHI is the UK’s leading industry association for health technology (HealthTech).

ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 131,800 people in 4,060 companies, with a combined turnover of £25.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 300 members account for approximately 80% of the sector by value.

About CPI
CPI works with partners to translate inventions into products and processes that enhance health and wellbeing, protect and improve our environment and increase productivity across industries.

With a deep understanding of technology fore-sighting, innovation processes and funding, outstanding technical expertise and industry-relevant assets, we enable the accelerated development of transformational products and processes that have the potential to disrupt and revolutionise markets.

Through the breadth of our technology platforms, we support our partners across many diverse markets, including pharmaceuticals, MedTech, , food and drink, FMCG, and electronics. Our approach to medtech covers the entire device development cycle, supporting companies from initial concept through to market adoption. Our multi-disciplinary teams provide the most suitable technical support, helping to overcome specific challenges to commercialise technology, all within the ISO 13485 Quality Management System. CPI’s experience and strong links with healthcare partners enables us to guide companies through the complex regulatory environment to gather the clinical and health economic evidence required for efficient medtech market adoption.